147 related articles for article (PubMed ID: 37288156)
1. Effect of Denosumab Therapy on Pain Level in Diffuse Sclerosing Osteomyelitis of the Mandible: a Case Report.
Jerković D; Jerković K; Lesin A; Poljičanin A; Galić I
Acta Stomatol Croat; 2023 Mar; 57(1):62-69. PubMed ID: 37288156
[TBL] [Abstract][Full Text] [Related]
2. Non-surgical treatment of adults with chronic diffuse sclerosing osteomyelitis/tendoperiostitis of the mandible.
van de Meent MM; Wetselaar-Glas MJM; Fiocco M; Appelman-Dijkstra NM; van Merkesteyn JPR
J Craniomaxillofac Surg; 2019 Dec; 47(12):1922-1928. PubMed ID: 31810841
[TBL] [Abstract][Full Text] [Related]
3. Ibandronate treatment of diffuse sclerosing osteomyelitis of the mandible: Pain relief and insight into pathogenesis.
Otto S; Troeltzsch M; Burian E; Mahaini S; Probst F; Pautke C; Ehrenfeld M; Smolka W
J Craniomaxillofac Surg; 2015 Nov; 43(9):1837-42. PubMed ID: 26421465
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate therapy in chronic diffuse sclerosing osteomyelitis/tendoperiostitis of the mandible: Retrospective case series.
van de Meent MM; Appelman-Dijkstra NM; Wetselaar-Glas MJM; Pichardo SEC; van Merkesteyn JPR
J Craniomaxillofac Surg; 2022 Jul; 50(7):599-604. PubMed ID: 35768318
[TBL] [Abstract][Full Text] [Related]
5. Conservative treatment of children with chronic diffuse sclerosing osteomyelitis/tendoperiostitis of the mandible.
van de Meent MM; Meshkini H; Fiocco M; Wetselaar-Glas MJM; Appelman-Dijkstra NM; van Merkesteyn JPR
J Craniomaxillofac Surg; 2017 Dec; 45(12):1938-1943. PubMed ID: 29102332
[TBL] [Abstract][Full Text] [Related]
6. Diffuse sclerosing osteomyelitis: a case series and literature review.
Matharu J; Taylor H; Sproat C; Kwok J; Brown J; Patel V
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 May; 129(5):437-446. PubMed ID: 32102763
[TBL] [Abstract][Full Text] [Related]
7. Outcome of different treatments for chronic diffuse sclerosing osteomyelitis of the mandible: a systematic review of published papers.
van de Meent MM; Pichardo SEC; Appelman-Dijkstra NM; van Merkesteyn JPR
Br J Oral Maxillofac Surg; 2020 May; 58(4):385-395. PubMed ID: 32035697
[TBL] [Abstract][Full Text] [Related]
8. Disodium clodronate in the treatment of diffuse sclerosing osteomyelitis (DSO) of the mandible.
Montonen M; Kalso E; Pylkkären L; Lindströrm BM; Lindqvist C
Int J Oral Maxillofac Surg; 2001 Aug; 30(4):313-7. PubMed ID: 11518354
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate therapy in the management of diffuse sclerosing osteomyelitis of the mandible: a systematic review and narrative synthesis.
Abukhder M; Nasri Elmi S; Van Der Lith S; Hawesa N; Abukhder D; Abid H; Liu L
Ann Med Surg (Lond); 2024 Feb; 86(2):950-957. PubMed ID: 38333319
[TBL] [Abstract][Full Text] [Related]
10. Treatment of diffuse sclerosing osteomyelitis of the jaw with denosumab shows remarkable results-A report of two cases.
Hallmer F; Korduner M; Møystad A; Bjørnland T
Clin Case Rep; 2018 Dec; 6(12):2434-2437. PubMed ID: 30564344
[TBL] [Abstract][Full Text] [Related]
11. Initial results of the treatment of diffuse sclerosing osteomyelitis of the mandible with bisphosphonates.
Kuijpers SC; de Jong E; Hamdy NA; van Merkesteyn JP
J Craniomaxillofac Surg; 2011 Jan; 39(1):65-8. PubMed ID: 20427193
[TBL] [Abstract][Full Text] [Related]
12. Total mandibular reconstruction following diffuse sclerosing osteomyelitis.
Rustemeyer J; Siegmund BJ; Okcu Y; Busch A
Oral Maxillofac Surg; 2019 Mar; 23(1):95-99. PubMed ID: 30327981
[TBL] [Abstract][Full Text] [Related]
13. Chronic Diffuse Sclerosing Osteomyelitis of the Mandible: The Use of Bisphosphonates as a Treatment for a Rare and Challenging Condition.
Keller E; Clocchiatti S; Rupel K; Ottaviani G; Ratti C; Canton G; Di Lenarda R; Murena L; Biasotto M
Medicina (Kaunas); 2024 May; 60(6):. PubMed ID: 38929534
[TBL] [Abstract][Full Text] [Related]
14. Radiographic characteristics of chronic diffuse sclerosing osteomyelitis/tendoperiostitis of the mandible: A comparison with chronic suppurative osteomyelitis and osteoradionecrosis.
van de Meent MM; Pichardo SEC; Rodrigues MF; Verbist BM; van Merkesteyn JPR
J Craniomaxillofac Surg; 2018 Sep; 46(9):1631-1636. PubMed ID: 30017711
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates and other bone agents for breast cancer.
Wong MH; Stockler MR; Pavlakis N
Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
[TBL] [Abstract][Full Text] [Related]
16. Treatment and prognosis of diffuse sclerosing osteomyelitis (DSO) of the mandible.
Jacobsson S; Hollender L
Oral Surg Oral Med Oral Pathol; 1980; 49(1):7-14. PubMed ID: 6927942
[TBL] [Abstract][Full Text] [Related]
17. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
[TBL] [Abstract][Full Text] [Related]
18. Diffuse sclerosing osteomyelitis (DSO) of the mandible in SAPHO syndrome: a novel approach with anti-TNF therapy. Systematic review.
Marí A; Morla A; Melero M; Schiavone R; Rodríguez J
J Craniomaxillofac Surg; 2014 Dec; 42(8):1990-6. PubMed ID: 25441866
[TBL] [Abstract][Full Text] [Related]
19. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
[TBL] [Abstract][Full Text] [Related]
20. Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: A systematic review within the European Association for Palliative Care guidelines project.
Porta-Sales J; Garzón-Rodríguez C; Llorens-Torromé S; Brunelli C; Pigni A; Caraceni A
Palliat Med; 2017 Jan; 31(1):5-25. PubMed ID: 27006430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
